Jubilant to market Technegas in US, signs pact with Cyclopharm

Last Updated: Monday, September 14, 2015, 13:21

Technegas is an imaging agent primarily used in Pulmonary Embolism (blockage of lung arteries).

Jubilant Life shares gain over 2% at close

Last Updated: Wednesday, June 17, 2015, 17:39

Trimming most of its initial gains on profit-booking, shares of Jubilant Life Sciences ended over 2 percent higher on Wednesday.

Aurobindo, Lupin & Jubilant get USFDA nod for hypertension drug

Last Updated: Tuesday, January 6, 2015, 19:47

Three domestic firms, Aurobindo Pharma, Lupin and Jubilant Life Sciences, have received final approval from US health regulator to sell generic copies of Valsartan tablets used for treatment of hypertension.

Jubilant acquires all outstanding shares of Cadista Holdings

Last Updated: Tuesday, December 23, 2014, 14:42

Jubilant Life Sciences has completed tender offer to acquire all outstanding shares of Cadista Holdings Inc, thereby making the US-based firm as its wholly-owned subsidiary.

Jubilant Life to split pharma business into two subsidiaries

Last Updated: Wednesday, May 29, 2013, 19:00

The company had posted consolidated net loss at Rs 30.97 crore for the fourth quarter ended March 31, 2013.

Jubilant Life Q3 net at Rs 27 cr due to robust sales

Last Updated: Tuesday, January 29, 2013, 15:57

The company had posted a net loss after taxes, minority interest and share of profit/loss of shareholders of Rs 78.39 crore for the corresponding period of previous fiscal, Jubilant Life Sciences said in a statement.